BOMBAY BURMAH TRADING CORPORATION
|
BOMBAY BURMAH TRADING CORPORATION Last 5 Year Financial Ratios History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | 160.90 | 91.24 | -240.22 | 9.09 | 52.96 |
CEPS(Rs) | 362.02 | 287.36 | -76.31 | 145.29 | 213.62 |
DPS(Rs) | 17.00 | 1.20 | 1.20 | 1.20 | 1.20 |
Book NAV/Share(Rs) | 807.16 | 663.35 | 577.92 | 787.79 | 782.85 |
Tax Rate(%) | 28.05 | 31.82 | 1,916.16 | 46.83 | 39.85 |
Margin Ratios | |||||
Core EBITDA Margin(%) | 16.33 | 17.25 | 16.02 | 14.60 | 17.22 |
EBIT Margin(%) | 16.75 | 15.83 | 2.69 | 11.62 | 16.23 |
Pre Tax Margin(%) | 15.92 | 13.81 | 0.24 | 9.95 | 15.15 |
PAT Margin (%) | 11.45 | 9.41 | -4.44 | 5.29 | 9.11 |
Cash Profit Margin (%) | 13.15 | 11.16 | -3.06 | 6.70 | 10.63 |
Performance Ratios | |||||
ROA(%) | 17.91 | 12.28 | -4.99 | 5.79 | 10.76 |
ROE(%) | 42.87 | 39.06 | -16.20 | 14.62 | 24.25 |
ROCE(%) | 46.17 | 32.87 | 4.27 | 18.06 | 29.81 |
Asset Turnover(x) | 1.56 | 1.31 | 1.12 | 1.09 | 1.18 |
Sales/Fixed Asset(x) | 3.31 | 3.34 | 3.76 | 3.83 | 3.72 |
Working Capital/Sales(x) | 64.48 | 18.89 | 5.85 | 3.90 | 6.64 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 0.30 | 0.30 | 0.27 | 0.26 | 0.27 |
Receivable days | 9.29 | 8.66 | 8.22 | 8.50 | 8.86 |
Inventory Days | 24.21 | 25.49 | 28.36 | 31.56 | 26.27 |
Payable days | 58.45 | 59.32 | 52.33 | 54.63 | 57.34 |
Valuation Parameters | |||||
PER(x) | 10.99 | 17.17 | - | 94.66 | 20.97 |
PCE(x) | 4.88 | 5.45 | -10.64 | 5.92 | 5.20 |
Price/Book(x) | 2.19 | 2.36 | 1.40 | 1.09 | 1.42 |
Yield(%) | 0.96 | 0.08 | 0.15 | 0.14 | 0.11 |
EV/Net Sales(x) | 0.73 | 0.71 | 0.51 | 0.50 | 0.66 |
EV/Core EBITDA(x) | 3.91 | 3.49 | 2.62 | 2.83 | 3.22 |
EV/EBIT(x) | 4.14 | 4.28 | 18.23 | 4.15 | 3.90 |
EV/CE(x) | 1.86 | 1.80 | 0.81 | 0.64 | 1.09 |
M Cap / Sales | 0.67 | 0.64 | 0.34 | 0.41 | 0.58 |
Growth Ratio | |||||
Net Sales Growth(%) | 6.95 | 2.92 | 14.58 | 8.29 | 12.67 |
Core EBITDA Growth(%) | -2.66 | 7.47 | 26.29 | -6.38 | 32.65 |
EBIT Growth(%) | 13.01 | 508.32 | -73.41 | -22.69 | 14.24 |
PAT Growth(%) | 30.02 | 319.20 | -196.33 | -37.30 | -0.20 |
EPS Growth(%) | 76.35 | 137.98 | -2,743.39 | -82.84 | -38.23 |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | 0.27 | 0.46 | 1.62 | 1.07 | 0.48 |
Current Ratio(x) | 1.07 | 1.22 | 1.55 | 1.81 | 1.54 |
Quick Ratio(x) | 0.75 | 0.93 | 1.31 | 1.51 | 1.24 |
Interest Cover(x) | 20.26 | 7.81 | 1.10 | 6.97 | 15.09 |
Total Debt/Mcap(x) | 0.12 | 0.20 | 1.15 | 0.98 | 0.34 |
Compare Financial Ratios of peers of BOMBAY BURMAH TRADING CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BOMBAY BURMAH TRADING CORPORATION | ₹12,844.9 Cr | -3% | -6.8% | -12.5% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,506.6 Cr | -2.1% | -8.1% | 4.2% | Stock Analytics | |
VENKYS (INDIA) | ₹2,124.2 Cr | 0.5% | -5.7% | -32% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,386.0 Cr | -2.3% | -4.4% | -29.6% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹531.6 Cr | -3.9% | -2.2% | NA | Stock Analytics | |
INDO US BIOTECH | ₹338.4 Cr | -3.4% | 8% | -21.2% | Stock Analytics |
BOMBAY BURMAH TRADING CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BOMBAY BURMAH TRADING CORPORATION | -3% |
-6.8% |
-12.5% |
SENSEX | -0.9% |
-4.4% |
1.6% |
You may also like the below Video Courses